Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals' PatentThe Supreme Court has granted a temporary emergency stay of a lower court order that Novartis Pharmaceuticals says would allow the development of as many as 20 generic versions of its commercially successful multiple-sclerosis drug, Gilenya.
The emergency application in Novartis Pharmaceuticals Corp. v. HEC Pharm Co. Ltd., court file 22A272, was filed with the court on Sept. 28 and granted Sept. 29 by Chief Justice John Roberts.
The applicant, Novartis, is headquartered in Basel, Switzerland; the respondent, HEC, a generic drug maker, is headquartered in Dongguan, China.
Novartis is known for developing a vaccine aimed at the virus that causes COVID-19, though that vaccine is not at issue in the current legal dispute....
Source: Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals' Patent (https://www.theepochtimes.com/supreme-court-grants-emergency-pause-on-ruling-disallowing-novartis-pharmaceuticals-patent_4763975.html)